“`html
Key Points
Microsoft achieved a market cap of $4 trillion earlier this year, reporting a first-quarter revenue of $77.7 billion for fiscal year 2026, a year-over-year increase of 18%. Additionally, Microsoft Azure experienced a 40% sales growth, concluding Q1 2026 with $392 billion in cloud obligations, up 51% from the previous year.
Eli Lilly, a new entrant to the trillion-dollar club, saw its market cap buoyed by the success of tirzepatide (Mounjaro), its best-selling drug. Although its market cap dipped below $1 trillion, tirzepatide’s performance in weight management and potential in other therapeutic areas like Alzheimer’s positions Eli Lilly for continued sales growth.
Both companies have appealing dividend programs, with Microsoft increasing its payouts by 152.8% over the past decade and Eli Lilly by 194%. Current forward yields stand at 0.8% for Microsoft and 0.6% for Eli Lilly.
“`
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
